¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"turbid plaque mutant"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dental plaque
    Ä¡ÅÂ
  • desmosomal plaque
    °áÇÕÆÇ
  • fibrous plaque
    ¼¶À¯ÆÇ
  • hemolytic plaque
    ¿ëÇ÷ÆÇ, ¿ëÇ÷ÇöóÅ©
  • hemolytic plaque assay
    ¿ëÇ÷ÆÇÃøÁ¤(¹ý), ¿ëÇ÷ÇöóÅ©ÃøÁ¤(¹ý)
  • hemolytic plaque-forming cell
    ¿ëÇ÷ÆÇÇü¼º¼¼Æ÷, ¿ëÇ÷ÇöóÅ©Çü¼º¼¼Æ÷
  • hybridization plaque
    Çöóũȥ¼ºÃ¼È­
  • large plaque parapsoriasis
    Å«ÆÇÀ¯»ç°Ç¼±, Å«ÆÇÀ¯»ç¸¶¸¥ºñ´ÃÁõ
  • mottled plaque
    ¹Ý»óÆÇ, Åé´Ï¸ð¾çÇöóÅ©
  • mucous patch plaque
    Á¡¸·ÆÇ
  • plaque
    ÆÇ, ÇöóÅ©
  • plaque assay
    ÆÇÃøÁ¤(¹ý), ÇöóÅ©ÃøÁ¤(¹ý)
  • plaque morphology mutation
    ÆÇÇüŵ¹¿¬º¯ÀÌ, ÇöóÅ©Çüŵ¹¿¬º¯ÀÌ
  • plaque technique
    ÇöóÅ©(±â)¹ý
  • plaque-forming unit
    ÇöóÅ©Çü¼º´ÜÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • atheromatous plaque
    Á×»óÆÇ
  • atherosclerotic plaque
    Á×»ó°æÈ­ÆÇ
  • atrophic large plaque parapsoriasis
    À§Ã༺ÆÇÀ¯»ç°Ç¼±
  • hemolytic plaque assay
    ¿ëÇ÷ÆÇÃøÁ¤¹ý, ¿ëÇ÷ÇöóÅ©ÃøÁ¤¹ý
  • plaque assay
    ÆÇÃøÁ¤¹ý, ÇöóÅ©ÃøÁ¤¹ý
  • hemolytic plaque-forming cell
    ¿ëÇ÷ÆÇÇü¼º¼¼Æ÷, ¿ëÇ÷ÇöóÅ©Çü¼º¼¼Æ÷
  • dental plaque
    Ä¡¸é¼¼±Õ¸·, Ä¡ÅÂ, Ä¡¾ÆÆÇ
  • desmosomal plaque
    ºÎÂøÆÇ
  • fibrous plaque
    ¼¶À¯ÆÇ
  • hemolytic plaque
    ¿ëÇ÷ÇöóÅ©, ¿ëÇ÷ÆÇ
  • hemolytic plaque test
    ¿ëÇ÷ÇöóÅ©°Ë»ç
  • hybridization plaque
    ÇöóÅ©ºÎÇÕ¹ý
  • mottled plaque
    ¿ë±ÕÆÇ, Åé´Ï¸ð¾çÇöóÅ©
  • mucous patch plaque
    Á¡¸·ÆÇ
  • plaque morphology mutation
    (¢¡plaque-type mutation) ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hemolytic plaque test
    ¿ëÇ÷ÇöóÅ©Å×½ºÆ®.
  • hemolytic plaque-forming cell
    ¿ëÇ÷¹Ý Çü¼º¼¼Æ÷, ¿ëÇ÷ÇöóÅ© Çü¼º¼¼Æ÷
  • hybridization, plaque
    ÇöóÅ©ºÎÇÕ¹ý(ݬùêÛö)
  • phage plaque-forming unit
    ÆÄÁö¿ë±Õ Çü¼º´ÜÀ§, ÆÄÁöÇöóÅ© Çü¼º´ÜÀ§
  • plague pneumonia ³ª p. plaque
    Æä½ºÆ®Æó·Å(¡­øËæú).
  • plague pneumonia ³ª p. plaque
    Æä½ºÆ®Æó·Å(¡­øËæú).
  • plaque
    ÇöóÅ©, ¿ë±Õ¹ÝÁ¡
  • plaque
    ÆÇ(÷ù), ¹Ý(Úï), ÇöóÅ©
  • plaque assay
    ÇöóÅ© ÃøÁ¤¹ý
  • plaque assay, hemolytic
    ¿ëÇ÷¼º ÇöóÅ© Çü¼º½ÃÇè
  • plaque formation
    ÇöóÅ©Çü¼º(¡­û¡à÷).
  • plaque formation
    ÇöóÅ© Çü¼º
  • plaque forming cell
    ÇöóÅ©Çü¼º¼¼Æ÷(¡­û¡à÷á¬øà).
  • plaque forming unit =PFU
    ÇöóÅ©Çü¼º ´ÜÀ§(¡­Ó¤êÈ).
  • plaque forming unit(PFU)
    ÇöóÅ© Çü¼º ´ÜÀ§
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ(¡­ë¶îîí­).
  • mutant gene
    µ¹¿¬º¯ÀÌÀ¯ÀüÀÚ
  • mutant species
    µ¹¿¬º¯ÀÌÁ¾(ÔÍæÔܨì¶ðú).
  • mutant(s)
    º¯ÀÌü(ܨì¶ô÷).
  • mutant, conditional lethal
    Á¶°ÇÄ¡»ç µ¹¿¬º¯ÀÌÁÖ
  • mutant, deletion
    °á¼ÕÇü µ¹¿¬º¯ÀÌÁÖ
  • mutant, host range
    ¼÷ÁÖ¿ª µ¹¿¬º¯ÀÌÁÖ
  • mutant, temperature-sensitive
    ¿Âµµ °¨¼ö¼º µ¹¿¬º¯ÀÌÁÖ
  • nutritional mutant
    ¿µ¾çº¯ÀÌÁÖ(~ܨì¶ñ»).
  • temperature sensitive mutant
    ¿Âµµ¹Î°¨µ¹¿¬º¯ÀÌÁÖ(è®öôÚÂÊïÔÍæÔܨì¶ñ»).
  • temperature-sensitive mutant
    ¿Âµµ¹Î°¨[µ¹¿¬]º¯ÀÌÁÖ
  • virulent mutant
    µ¶¼º µ¹¿¬º¯ÀÌÁÖ
  • virulent mutant
    µ¶¼º(µ¹¿¬)º¯ÀÌ(±Õ)ÁÖ(¡­ÔÍæÔܨì¶Ð¶ñ»).
  • artherosclerosis,atheromatous plaque
    Á×»ó ÆÇ
  • assay, hemolytic plaque
    ¿ëÇ÷¹Ý ÃøÁ¤¹ý, ¿ëÇ÷ÇöóÅ© ÃøÁ¤¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • asporogenous mutant
    Ȧ¾¾ºÒÇü¼º º¯ÀÌÁ¾ (ÝÕû¡à÷ ܨì¶ðú)
  • biochemically deficient mutant
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) °áÇ̺¯ÀÌÁ¾(ÌÀù¹Ü¨ì¶ðú)
  • biochemical mutant
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) º¯ÀÌÁ¾(ܨì¶ðú)
  • cofactor-requiring mutant
    º¸(Á¶)ÀÎÀڿ䱸 º¯ÀÌü(ÜÍ(ð¾)ì×í­é©Ï´Ü¨ì¶ô÷)
  • cold-sensitive mutant
    ³Ã¹Î°¨ º¯ÀÌü(Ò²ÚÂÊïܨì¶ô÷)
  • conditional lethal mutant
    Á¶°ÇºÎ Ä¡»çº¯ÀÌü(ðÉËìݾöÈÞÝܨì¶ô÷)
  • conditional mutant
    Á¶°ÇºÎ º¯ÀÌü(ðÉËìݾܨì¶ô÷)
  • cryptic mutant
    ÀáÀç º¯ÀÌü(íÖî¤Ü¨ì¶ô÷)
  • deficiency mutant
    "°áÇÌ º¯ÀÌü(ÌÀù¹Ü¨ì¶ô÷), (ÔÒ) auxotroph"
  • DNA-arrest mutant
    DNAÁ¤Áö(ïÎò­) º¯ÀÌü(ܨì¶ô÷)
  • DNA-delay mutant
    DNAÁöü º¯ÀÌü(òÀôòܨì¶ô÷)
  • DNA-negative mutant
    ¹«(Ùí)DNA º¯ÀÌü(ܨì¶ô÷)
  • dual-effect mutant
    ÀÌÁßÈ¿°ú º¯ÀÌü(ì£ñìüùÍýܨì¶ô÷)
  • host-range mutant
    ¼÷ÁÖ¹üÀ§ º¯ÀÌÁÖ(âÖñ«ÛôêÌܨì¶ñ»)
  • leaky mutant
    ´©Ã⺯ÀÌü(שõóܨì¶ô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
LPF leukocytosis-promoting factor; leukopenia factor; lipopolysaccharide factor; localized plaque format...
PFC pair-fed control [mice]; patient-focused care; pelvic flexion contracture; perfluorocarbon; pericard...
PFU plaque-forming unit; pock-forming unit
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MUT mutant
MF mutant frequencies
TTR mutant transthyretin
PFU Plaque Forming Unit
LP Large plaque
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mottled plaque
    ¿ë±Õ ¹Ý
  • opaline plaque
    ´Ü¹é¼®¾ç ¹Ý
  • plaque control
    ġŠÁ¶Àý
  • plaque formation
    º´¼Ò ¹Ý Çü¼º, ÇöóÅ© Çü¼º
    ȹµæ ÇǸ·ÀÇ Çü¼º, ȹµæ ÇǸ·¿¡ ¼¼±ÕÀÇ ÃʱâºÎÂø, ¼¼±Õ¼º ġŰ¡ ¸î ÃþÀ¸·Î ÃàÀûµÇ¾î µÎ²¨¿öÁö´Â °úÁ¤À» ¸»ÇÑ´Ù.
  • plaque forming unit
    ÇöóÅ© Çü¼º ´ÜÀ§
  • plaque like
    ¹ÝÁ¡ °°Àº
  • plaque like lesion
    ¹ÝÁ¡ °°Àº º´¼Ò
  • plaque-like
    ¹ÝÁ¡Çü, ¹ÝÇü
  • scleroderma in plaque
    ġų» °øÇÇÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
neuritic plaque <cell biology> Abnormal cluster of dead and dying nerve cells, other brain cells and protein.
Neuritic plaques are one of the characteristic structural abnormalities found in the brains of alzheimer patients. Upon autopsy, the presence of neuritic plaques andneurofibrillary tangles is used to positively diagnose Alzheimer's disease.
(22 May 1997)
dental plaque <dentistry> A soft, thin film of food debris, mucin and dead epithelial cells deposited on the teeth, providing the medium for the growth of various bacteria.
The main inorganic components are calcium and phosphorus with small amounts of magnesium, potassium and sodium, the organic matrix consists of polysaccharides, proteins, carbohydrates, lipids and other components.
Plaque plays an important aetiological role in the development of dental caries and periodontal and gingival diseases and provides the base for the development of materia alba, calcified plaque forms dental calculus.
(19 Mar 1998)
dental plaque index An index which scores the degree of dental plaque accumulation.
(12 Dec 1998)
fibrous plaque Thickened area of arterial intima with accumulation of smooth muscle cells and fibrous tissue (collagen etc.) produced by the fat laden smooth muscle cells. Below the thickening may be free extracellular lipid and debris that, if much necrosis is also present, is referred to as an atheroma.
(18 Nov 1997)
active mutant A mutant with overt phenotypic expression.
(05 Mar 2000)
amber mutant A mutant with a mutation resulting in a UAG codon.
(05 Mar 2000)
auxotrophic mutant Mutant with a nutritional requirement not present in the wild type organism.
Synonym: defective organism, deficiency mutant.
(05 Mar 2000)
gap mutant <molecular biology> A fruit fly of the genus Drosophila which is missing a number of adjacent segments because the segments failed to develop.
(09 Oct 1997)
rats, mutant strains Rats bearing mutant genes which are phenotypically expressed in the animals.
(12 Dec 1998)
virulent phage mutant A mutant of a phage that is unable to establish lysogeny.
(05 Mar 2000)
relaxed mutant A mutant bacterium that continues to synthesise RNA in a medium that lackscertain nutrients or amino acids which that sort of bacterium normallyneeds present before it can make RNA.
(09 Oct 1997)
ced mutant <organism> Giant multinucleate fresh water amoeba (up to 5mm long) much used for studies on the mechanism of cell locomotion.
(18 Nov 1997)
cell division cycle mutant A yeast cell which has cell division cycle genes that have mutated to become sensitive to temperature, at certain temperatures (usually high ones), various parts of the normal yeast cell cycle become abnormal, and in some strains the yeast cell does not survive at all.
(09 Oct 1997)
petite mutant <molecular biology, organism> A class of yeast mutants, most studied in Saccharomyces cerevisiae. Mutants grow slowly and rely on anaerobic respiration: mitochondria, although present, have reduced cristae and are functionally defective (termed promitochondria). There are three types of petite mutant:
(i) Segregational mutants that show Mendelian behaviour and result from mutations in mitochondrial genes located in the nucleus.
(ii) Neutral petites, which are recessive genotypes and result from the complete absence of mitochondrial DNA.
(iii) Suppressive petites, in which most of the mitchondrial DNA is lost (60-99%), though what remains is often amplified.
(06 Oct 1997)
mice, mutant strains Mice bearing mutant genes which are phenotypically expressed in the animals.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á